Dr Devanshi Seth
|
Clinical Senior Lecturer
C39 - Royal Prince Alfred Hospital |
|
On this page
Themes | Biographical details | Research interests | Honours project opportunities | Keywords | International links
Biographical details
Dr Seth, BSc (Hons), MSc (Agriculture), MPH, PhD (Genetics), is Senior Scientist and Clinical Senior Lecturer at the (i) Drug Health Services (DHS), (ii) Centenary Institute (CI) at RPAH; and at the University of Sydney (USYD), Clinical and Addiction Medicine. Dr Devanshi Seth has more than 25 years of training and experience as Molecular Biologist, Biotechnology industry and more recently in Public Health, with 10 years of contribution towards alcohol research. Dr Seth has several publications in peer reviewed high impact journals in this area. Her work is being increasingly recognised internationally through invitations to chair and present at international meetings and has generated several national and international collaborations. She also has long term collaboration with Prof Geoff McCaughan, Director AW Morrow Gastroenterology & Liver Clinic, RPAH and Prof Paul Haber, Medical Director, DHS, Sydney South West Area Health Service (SSWAHS). Several current research interests in Dr Seth's group encompass from basic understanding of molecular pathogenesis to genetic and other risk factors for ALD as well as treatment options for patients with ALD. [More...]
Research interests
Dr Devanshi Seth is committed to research in alcohol to understand the molecular pathogenesis, associated risk factors and prevention and treatment of alcoholic liver disease (ALD).
Areas of research: Chronic Alcohol; Alcohol related organ damage; Alcoholism; Addiction; Liver Cirrhosis/Fibrosis
Opportunities for Honours and PhD: All current research listed above have opportunity for students as honours and/or PhD projects.
Honours project opportunities
Genetic factors that predict liver disease amongst excessive alcohol drinkers: a pilot genome wide analysis using Illumina single nucleotide polymorphism (SNP) chips
To investigate Secreted phosphoprotein 1 (SPP1) mediated liver fibrogenesis in alcoholic liver injury
To investigate the mechanism/s of injury in liver injury models of alcohol and high fat diet
International links
United States. (Indiana University, Bloomington, IN) Lawrence Lumeng, M.D. is a Professor, Physician/Scientist at the Indiana University, Bloomington, IN. He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011..
Switzerland. (University of Bern, Switzerland) Felix Stickel, M.D. is an Associate Professor and GI specialist at the University of Heidelberg and University of Eirlangen, Germany and Head, Dept. of Visceral Surgery and Medicine, University of Bern. He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011..
United Kingdom. (University of Newcastle, UK) DAY, Christopher Paul, MD, MRCP, PhD, FRCP is Pro Vice Chancellor of Medical Sciences & Professor of Liver Medicine at the University of Newcastle, UK. He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011. Prof Day and Dr Seth have also published together recently in Hepatology..
United States. (University of California, LA
Indiana school of Medicine, Indianpolis) Prof Tatiana Foroud, B.s, M.S, PhD is Professor of Medical & Molecular Genetics. She is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011. Dr Seth and Prof Foroud have jointly organised symposium on GWAS at the ISBRA 2008 meeting..
Germany. (Salem Medical Center, Heidelberg
Centre of Alcohol Research Liver Disease and Nutrition, University of Heidelberg) Helmut Karl Seitz, M.D., PhD, AGAF is Professor, Medical Director, Department of Medicine, Salem Medical Center, Heidelberg;
Head, Centre of Alcohol Research Liver Disease and Nutrition.
He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011..
United States. (University of California-Irvine
VA Medical Center, Long Beach CA) Timothy R, MORGAN, MD is Professor of Medicine, University of California, Irvine and Chief, Hepatology at the VA Medical Centre. He is the lead US Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011..
France. (University Paris XII, France) Bertrand Nalpas, M.D, PhD, is Director of research at the University Paris VII, France. He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011..
Australia. (Queensland Institute of Medical Research, Brisbane) John B Whitfield, BSc, MSC, PhD, MRCPath, FRCPath is the Director a Senior Principal Research Fellow at the Genetic Epidemiology, Queensland Institute of Medical Research, Brisbane. He is one of the Principal Investigators and collaborator in the GenomALC Consortium, a 5-year multi-national project "To identify genetic risk factors that predispose some heavy drinkers to develop cirrhosis" supported by the National Institute of Health (NIH) / National Institute on Alcohol Abuse and Alcoholism (NIAAA), due to commence 2011. Drs Whitfield and Seth have had ~8 years of collaboration and held joint grants during this period..